I-Mab to Release Q3 2024 Financial Results on November 14, 2024
Press Releases
I-MAB Biopharma  
October 31, 2024

I-Mab to Release Q3 2024 Financial Results on November 14, 2024

ROCKVILLE, Md., Oct. 31, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company"), a US-based, global biotech company, exclusively focused on the development of highly differentiated immunotherapies for the treatment of

avatar profile Olean Times Herald

Olean Times Herald


Local & Social